Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (35)

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

2022

  1. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

2021

  1. Mitochondria-ER contacts and glucose: the powerhouse of Alzheimer's disease?

    Cell Calcium

2020

  1. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Effects of ABO matching of platelet transfusions in critically III children

    Pediatric Critical Care Medicine, Vol. 20, Núm. 2, pp. E61-E69

  2. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children with an Underlying Oncologic Diagnosis

    Pediatric Critical Care Medicine, Vol. 20, Núm. 7, pp. e342-e351

  3. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis

    Hepatology, Vol. 70, Núm. 2, pp. 496-510

2018

  1. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

    Journal of Thrombosis and Thrombolysis, Vol. 46, Núm. 4, pp. 551-558

  2. Platelet Transfusion Practices in Critically Ill Children

    Critical Care Medicine, Vol. 46, Núm. 8, pp. 1309-1317

2017

  1. IgG4-Related Disease: Gastrointestinal Involvement

    Handbook of Systemic Autoimmune Diseases (Elsevier Ltd), pp. 399-410

  2. Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 54, Núm. 5, pp. 3428-3438

2016

  1. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease

    European Journal of Neuroscience, Vol. 44, Núm. 12, pp. 3056-3066

2013

  1. Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice

    Psychoneuroendocrinology, Vol. 38, Núm. 11, pp. 2462-2475

  2. Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice

    IntraVital, Vol. 2, Núm. 2, pp. e25693

  3. Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice

    Journal of Neuropathology and Experimental Neurology, Vol. 72, Núm. 4, pp. 272-285

2012

  1. Reducing available soluble β-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 11, pp. 1009-1017

2011

  1. Cerebrovascular lesions induce transient β-amyloid deposition

    Brain

2010

  1. Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice

    Neurobiology of Aging, Vol. 31, Núm. 12, pp. 2058-2068

2009

  1. Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575

    Molecular Neurodegeneration, Vol. 4, Núm. 1

  2. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice

    Journal of Neurochemistry, Vol. 109, Núm. 6, pp. 1636-1647